DrugPatentWatch Database Preview

Drugs in Development Information for Mibefradil

« Back to Dashboard

Summary for Mibefradil

US Patents	902
International Patents	7,426
US Patent Applications	1,718
WIPO Patent Applications	1,105
Japanese Patent Applications	5
Clinical Trial Progress	Phase 1 (2018-05-28)
Vendors	26

US Patents for Mibefradil

Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration
Mibefradil		Ethylsulfonated hyaluronic acid biopolymers and methods of use thereof	The Regents of the University of California (Oakland, CA)
Mibefradil		Neprilysin inhibitors	THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA)
Mibefradil		Synthetic linear apelin mimetics for the treatment of heart failure	NOVARTIS AG (Basel, CH)
Mibefradil		DHA-pharmaceutical agent conjugates of taxanes	Neuromedica, Inc. (Conshohocken, PA)
Mibefradil		Preparation of mibefradil via an acetamide anion	Roche Colorado Corporation (Boulder, CO)
Mibefradil		Preparation of mibefradil via a naphthalenylacetic acid	Roche Colorado Corporation (Boulder, CO)
Mibefradil		Preparation of mibefradil via an acetonitrile anion	Roche Colorado Corporation (Boulder, CO)

International Patents for Mibefradil

Drugname	Country	Document Number	Estimated Expiration	Related US Patent
Mibefradil	European Patent Office	2981556	2033-04-02
Mibefradil	World Intellectual Property Organization (WIPO)	2014165513	2033-04-02
Mibefradil	Australia	2015210983	2034-01-30
Mibefradil	Canada	2934936	2034-01-30
Mibefradil	China	105992763	2034-01-30
Mibefradil	European Patent Office	3099678	2034-01-30
Mibefradil	Japan	2017507921	2034-01-30